BioCryst Reports Second Quarter 2017 Financial Results
Go back to BioCryst Reports Second Quarter 2017 Financial Results| BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) | Delayed: 9.86 -0.73 (6.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.59 | 52 Week High | $10.98 | |||
| Open | $10.59 | 52 Week Low | $1.63 | |||
| Day High | $10.63 | P/E | N/A | |||
| Day Low | $9.85 | EPS | $-0.68 | |||
| Volume | 1,943,255 | |||||

